A
Alcista
Alcista · 25%IMCC
$3.63
Precio del escenario
$1.390
+0.063 (+4.51%)Al cierre
Loading chart…
- Máximo
- 1.460
- Apertura
- 1.310
- Precio medio ponderado por volumen
- 1.39
- Volumen
- 86.02K
- Capitalización
- 6.03M
- Mínimo
- 1.310
- Importe
- 119.27K
- EV/EBITDA, TTM
- -0.64
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Análisis de IA of IM Cannabis Corp (IMCC)
VenderIM Cannabis Corp. is not a good buy right now due to its significant financial struggles and negative market sentiment. The stock has dropped 96.89% year-to-date, and the current RSI is at 27.00, indicating it is oversold but still under pressure. Additionally, the company reported a net income loss of CAD 4.36 million in Q2 2026, which raises concerns about its profitability and sustainability.
Métricas de valoración
El PER previsto actual de IM Cannabis Corp (IMCC) es 42.37, frente a su media de 5 años de -0.53.
Escenarios de precio de Alphio AI para IMCC
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
8.509-29PRnewswireIM Cannabis Completes Share Transaction Expected to Boost Shareholders' Equity by C$3 Million
8.509-29NewsfilterIM Cannabis Completes Share Transaction, Expected C$3 Million Increase in Shareholders' Equity
8.509-23PRnewswireIM Cannabis Corp. Regains Nasdaq Compliance
8.509-23NASDAQ.COMIM Cannabis Corp. Prices Direct Offering Raising $1.31 Million
2.009-23PRnewswireIM Cannabis Corp. Completes Sale of 655,000 Shares in Direct Offering
Preguntas frecuentes sobre IMCC, respondidas por Alphio AI
IM Cannabis Corp. is an international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The Company's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower. It operates in the Consumer Non-Cyclicals sector (MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS industry).
IM Cannabis Corp. is not a good buy right now due to its significant financial struggles and negative market sentiment. The stock has dropped 96.89% year-to-date, and the current RSI is at 27.00, indicating it is oversold but still under pressure. Additionally, the company reported a net income loss of CAD 4.36 million in Q2 2026, which raises concerns about its profitability and sustainability.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.